NIH-funded research Career grant

Investigating the role of SNX19 in aging brains and Alzheimer's disease

Official title: The role of SNX19 in aging brains at single cell resolution and cerebral organoids

Funded at University of Texas Hlth Science Center · NIH-10984597 · Data updated 2026-11-12

This study is looking at how a protein called SNX19 might play a role in aging brains and Alzheimer's disease, using brain samples and lab-grown brain cells to find out more, with the hope of discovering new ways to help people with Alzheimer's.

More Aging research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Science Center
NIH-funded
Lab location1 site (San Antonio, United States)
Project startAugust 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$118,557
NIH project number1K01AG084813-01A1
Project IDNIH-10984597 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a genetic predisposition to Alzheimer's disease, particularly those carrying the APOE ε4 allele.

Less likely to help

Patients with non-neurodegenerative conditions or those without a family history of Alzheimer's disease may not receive benefit from this research.

What this research studies

This research focuses on understanding how the SNX19 protein affects aging brains and contributes to Alzheimer's disease and related dementias. By examining postmortem brain tissue at a single-cell level and using human-derived brain organoids, the study aims to uncover the mechanisms linking SNX19 to neurodegenerative processes. The approach includes advanced techniques like single molecule in situ hybridization and RNA sequencing to analyze gene expression and its association with Alzheimer's-related pathologies. Patients may benefit from insights that could lead to new treatment strategies for Alzheimer's disease.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic targets for treating Alzheimer's disease and improving patient outcomes.

How similar studies have gone: Previous research has shown promising results in understanding neurodegenerative diseases through similar cellular and molecular approaches, suggesting potential for success in this area.

Where this research is happening

  • University of Texas Hlth Science Center
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Ma, Liang — University of Texas Hlth Science Center
  • Study coordinator: Ma, Liang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.